BR9711560A - Compostos de heteariloxietiaminas processo de prepara-Æo dos mesmos uso dos mesmos e composi-{es farmac-uticas - Google Patents

Compostos de heteariloxietiaminas processo de prepara-Æo dos mesmos uso dos mesmos e composi-{es farmac-uticas

Info

Publication number
BR9711560A
BR9711560A BR9711560A BR9711560A BR9711560A BR 9711560 A BR9711560 A BR 9711560A BR 9711560 A BR9711560 A BR 9711560A BR 9711560 A BR9711560 A BR 9711560A BR 9711560 A BR9711560 A BR 9711560A
Authority
BR
Brazil
Prior art keywords
hetearyloxyethiamin
pharmaceutical compositions
preparation process
same use
compounds preparation
Prior art date
Application number
BR9711560A
Other languages
English (en)
Inventor
Dennis Bigg
Marie-Odile Galcera
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of BR9711560A publication Critical patent/BR9711560A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • C07D215/28Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9711560A 1996-09-27 1997-09-26 Compostos de heteariloxietiaminas processo de prepara-Æo dos mesmos uso dos mesmos e composi-{es farmac-uticas BR9711560A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611798A FR2753968B1 (fr) 1996-09-27 1996-09-27 Nouvelles heteroaryloxyethylamines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
PCT/FR1997/001691 WO1998013349A2 (fr) 1996-09-27 1997-09-26 Heteroaryloxyethylamines en tant que ligands 5-ht¿1a?

Publications (1)

Publication Number Publication Date
BR9711560A true BR9711560A (pt) 1999-08-24

Family

ID=9496126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711560A BR9711560A (pt) 1996-09-27 1997-09-26 Compostos de heteariloxietiaminas processo de prepara-Æo dos mesmos uso dos mesmos e composi-{es farmac-uticas

Country Status (21)

Country Link
US (1) US6063784A (pt)
EP (1) EP0929525B1 (pt)
JP (1) JP2001503393A (pt)
AR (1) AR008486A1 (pt)
AT (1) ATE223380T1 (pt)
AU (1) AU731459B2 (pt)
BR (1) BR9711560A (pt)
CA (1) CA2267247C (pt)
DE (1) DE69715223T2 (pt)
DK (1) DK0929525T3 (pt)
ES (1) ES2182120T3 (pt)
FR (1) FR2753968B1 (pt)
HU (1) HUP0001189A3 (pt)
IL (1) IL128917A (pt)
MY (1) MY118992A (pt)
NO (1) NO311935B1 (pt)
NZ (1) NZ334623A (pt)
PL (1) PL190221B1 (pt)
RU (1) RU2176639C2 (pt)
TW (1) TW425390B (pt)
WO (1) WO1998013349A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4507398B2 (ja) * 1999-12-06 2010-07-21 宇部興産株式会社 3−ハロメチルオキセタン化合物の合成方法
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
RU2234315C1 (ru) * 2003-06-30 2004-08-20 Государственный научный центр - Институт биофизики Фармацевтическая композиция, содержащая ондансетрон, метацин и бензамид

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003681A1 (en) * 1987-10-19 1989-05-05 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
US5240800A (en) * 1991-07-29 1993-08-31 Eastman Kodak Company Near-infrared radiation sensitive photoelectrographic master and imaging method
EP0643045B1 (de) * 1993-09-10 2000-03-08 Novartis AG Chinolin-Verbindungen als Leukotriene Antagonisten
GB9507288D0 (en) * 1995-04-07 1995-05-31 Sod Conseils Rech Applic Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors

Also Published As

Publication number Publication date
ES2182120T3 (es) 2003-03-01
FR2753968A1 (fr) 1998-04-03
PL190221B1 (pl) 2005-11-30
WO1998013349A3 (fr) 1998-11-05
CA2267247A1 (fr) 1998-04-02
AU731459B2 (en) 2001-03-29
EP0929525A2 (fr) 1999-07-21
IL128917A (en) 2003-10-31
NO991481D0 (no) 1999-03-26
RU2176639C2 (ru) 2001-12-10
AU4463797A (en) 1998-04-17
IL128917A0 (en) 2000-02-17
NO991481L (no) 1999-03-26
DE69715223T2 (de) 2003-04-30
ATE223380T1 (de) 2002-09-15
EP0929525B1 (fr) 2002-09-04
TW425390B (en) 2001-03-11
FR2753968B1 (fr) 1998-11-27
JP2001503393A (ja) 2001-03-13
DK0929525T3 (da) 2002-12-02
PL332480A1 (en) 1999-09-13
AR008486A1 (es) 2000-01-19
WO1998013349A2 (fr) 1998-04-02
CA2267247C (fr) 2009-05-05
MY118992A (en) 2005-02-28
DE69715223D1 (de) 2002-10-10
HUP0001189A3 (en) 2001-12-28
US6063784A (en) 2000-05-16
NZ334623A (en) 1999-09-29
NO311935B1 (no) 2002-02-18
HUP0001189A2 (hu) 2000-10-28

Similar Documents

Publication Publication Date Title
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR9508586A (pt) Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
BR9707501A (pt) Composto composição farmacêutica e uso do composto
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
BR9707139A (pt) Utilização de uma quantidade eficaz de uma associação composições processo de preparação de composições uso de um produto e artigos
PT850948E (pt) Derivados propiofenona e processo para a preparacao dos mesmos
BR9406566A (pt) Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica
BR9603429A (pt) Derivado de 11-(fenila substituída) estra-4,9-dieno processo de preparação do mesmo composição farmacêutica e uso deste derivado
BR9509200A (pt) Composição de matéria
BR9706311A (pt) Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética
EE03380B1 (et) Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod
BR9600930A (pt) Derivados de n-(3-benzofuranil)uréia processo para sua preparação composição processo para a preparação de composições e uso
BRPI0107815B8 (pt) compostos derivados aminados de di-hidro-1,3,5- triazina, processo de preparo destes, composição farmacêutica e uso dos mesmos
BR9505107A (pt) Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
BR9707808A (pt) Composto composição farmacêutica e uso do composto
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
BR9708790A (pt) Composto uso de um composto e formulação farmacêutica
BR9708141A (pt) Composto processo sua preparação uso de composto e composição famracêutica
BR9707261A (pt) Compostos processos de preparação dos mesmos e de produtos e composições farmacéuticas
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
BR9610530A (pt) Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos
BR9600339A (pt) Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time